Impact of COVID-19 on services for people with disabilities and chronic health conditions

Disabil Health J. 2021 Jul;14(3):101090. doi: 10.1016/j.dhjo.2021.101090. Epub 2021 Mar 5.

Abstract

Background: People with disabilities and chronic health conditions rely on a range of services and supports to complete daily tasks, maintain health, and participate in the community. Preliminary research suggests the COVID-19 pandemic greatly disrupted these services and this population may be particularly susceptible to unemployment.

Objective: Describe employment and service disruptions for individuals with disabilities and chronic health conditions during the onset of community-based spread of COVID-19 in the United States.

Methods: Adults with disabilities and chronic health conditions completed online surveys to report employment and service changes via multiple choice and open-ended questions. Multiple choice questions were analyzed using descriptive statistics; open-ended responses were coded using content analysis.

Results: Participants (n = 109): 79.8% female, 88.1% white, 77.121% completed a 4-year college degree or greater, 61.4% had annual income ≥$45,000. Only 14.9% of survey respondents reported disruptions in employment. On average, 54.0% of service changes were due to discontinuation, including loss of physical therapy, job coaching, community organizations, transportation, and peer supports. Other changes included a shift to virtual service delivery and family members taking the role of service providers.

Conclusions: Individuals with chronic health conditions and disabilities experienced service disruptions, even in a sample with considerably more economic, social, and educational privilege than the general population of people with chronic health conditions and disabilities in the United States.

Keywords: COVID-19; Chronic disease; Disability; Employment; Health services.

MeSH terms

  • Adult
  • COVID-19*
  • Chronic Disease
  • Disabled Persons*
  • Female
  • Humans
  • Male
  • Pandemics
  • SARS-CoV-2
  • United States